Ibrutinib blocks BTK and is used for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, and Waldenström’s Macroglobulinemia. It really messes with cancer cell growth and survival by blocking that BTK thing. You can get it in 140 mg capsules or tablets.
They usually suggest taking 420 to 560 mg a day. Each bottle has 90 tablets.